Depression and Anxiety Trial, Recruiting NCT07554755 Sponsor: The Second Hospital of Anhui Medical University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07554755
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with major depressive disorder (a formal diagnosis of serious, ongoing depression) according to standard medical guidelines known as DSM-5.
  • People aged 12 to 22 years old who have at least one parent or guardian available to monitor them throughout the 3-month study period.
  • People whose depression is rated as moderately severe or above on a standard medical scoring tool called the HAMD-17 (a score of 18 or higher).
  • People who have harmed themselves without the intention of ending their life on two or more occasions in the 2 weeks before entering the study, and who have done so on more than 5 days in the past year, meeting specific DSM-5 criteria for this behaviour.
  • People (and their guardians) who have given their formal written agreement to take part in the trial.

Who may not be able to join:

  • People who use substances such as alcohol or mind-altering drugs in a way that is considered abuse.
  • People with a serious physical disability that would prevent them from attending follow-up appointments.
  • People who also have another major mental health condition diagnosed under DSM-5 guidelines, such as bipolar disorder, schizophrenia, intellectual disability, dementia, severe memory or thinking problems, or attention deficit hyperactivity disorder (ADHD).
  • People who have ever had a severe physical illness, a neurological (brain or nervous system) condition, or a traumatic brain injury that has affected how their brain is structured or works.
  • People who are unable to read, understand, or complete the study assessments, or who are unable to cooperate with the research team.
  • People who have a pacemaker, metal or magnetic objects in their body, or any other condition that makes a specific type of brain stimulation treatment used in this trial (called TIS) unsuitable for them.
  • People who have received certain structured talking therapies (such as interpersonal therapy, dynamic therapy, or cognitive behavioural therapy) or a brain stimulation treatment called TMS in the 3 months before the study begins.
  • People whose test results or other factors are considered by the research team to make participation unsuitable (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-13955188448

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Second Hospital of Anhui Medical University
Registry
ClinicalTrials.gov
Start date
30 April 2026
Est. completion
30 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Changes in the Adolescent Non-Suicidal Self-Injurious Behavior Assessment Questionnaire (ANSAQ); Changes in the 17-item Hamilton Rating Scale for Depression (HAMD-17)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov